Clinical trial
CK0801 for Treatment of Aplastic Anemia
NCT07499102 is registered in ClinicalTrials.gov with Cellenkos, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CK0801 for Treatment of Aplastic Anemia
- Lead sponsor
- Cellenkos, Inc.
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- August 3, 2026
- Completion date
- August 3, 2029
- Enrollment
- 12 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aplastic anemia